Taekyung Chemical태경케미컬
006890 · KOSPI · ₩006890 · 태경케미컬
₩4,240▼ ₩145 (3.31%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩61B | ₩71B | ₩71B | ₩60B | ₩54B |
| Cost of sales | ₩45B | ₩43B | ₩39B | ₩36B | ₩31B |
| Gross profit | ₩16B | ₩28B | ₩32B | ₩23B | ₩23B |
| Operating income | ₩2.1B | ₩14B | ₩18B | ₩10B | ₩12B |
| Net income | ₩8.7B | ₩13B | ₩17B | ₩8.7B | ₩11B |
| Net income to shareholders | ₩8.7B | ₩13B | ₩17B | ₩8.9B | ₩11B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩224B | ₩184B | ₩183B | ₩167B | ₩161B |
| Current assets | ₩38B | ₩58B | ₩69B | ₩66B | ₩62B |
| Cash and equivalents | ₩10B | ₩26B | ₩10B | ₩22B | ₩5.8B |
| Total liabilities | ₩52B | ₩21B | ₩21B | ₩20B | ₩20B |
| Current liabilities | ₩7.9B | ₩15B | ₩12B | ₩12B | ₩10B |
| Borrowings | ₩40B | — | — | — | — |
| Total equity | ₩173B | ₩164B | ₩162B | ₩147B | ₩141B |
| Shareholders' equity | ₩173B | ₩164B | ₩162B | ₩147B | ₩141B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩7.2B | ₩14B | ₩20B | ₩10B | ₩13B |
| Capital spending | ₩15B | ₩21B | ₩17B | ₩5.9B | ₩4.6B |
| Free cash flow | −₩7.8B | −₩7.6B | ₩3.5B | ₩4.2B | ₩8.8B |
| Dividends paid | ₩2B | ₩2.3B | ₩2.3B | ₩2.5B | ₩2.3B |
Consolidated where available. Amounts in won.
Also known as: Taekyung Chemical / 태경케미컬 / 006890 / KRX:006890
Source: KRX statistical information